Location: Home
  • search
  • go
  • Relate News
  • 3/2/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (56...
  • 3/2/2022Gene Therapy Startup Grit Science Raises CNY Hundreds of Millions
  • 3/2/2022Tasly Reportedly Eyeing to Terminate License Pact with Sutro Biopharma
  • 3/2/2022The New Chinese Physicians Law Contains Provisions on Clinical Guideli...
  • 3/1/2022Financial-related Company News Digest
  • 3/1/2022Drug R&D and Product Registration News Digest February 2022 (3)
  • 3/1/2022Digestome Therapeutics Licenses Schizophrenia Drug DGX-001 for Greater...
  • 3/1/2022Heidelberg Pharma and Huadong Announce Strategic Partnership, Includin...
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • 2/26/2022CARsgen Therapeutics Opens New U.S. cGMP Facility for CAR T Production
  • 2/25/2022NMPA Announces Package Insert Revision of Proton Pump Inhibitor Drug F...
  • 2/25/2022CDE Issues the Technical Guidelines for Clinical Trials of Human Fibri...
  • 2/25/2022CDE Issues the Technical Guidance for Clinical Research of Human Rabie...
  • 2/23/2022Lepu Biopharma Launches IPO on the Main Board of HKEX
  • 2/23/202215 Category 4.1 Patent Invalidation Challenges Initiated in China afte...
  • 2/23/2022OBI and Odeon Enter $200M License Deal for China Rights of OBI-999 a...
  • 2/23/2022Kiniksa Pharma and Huadong Medicine Announce Strategic Collaboration
  • 2/23/2022New Report: Assessment of China's Oncology Drugs Market 2022-2027
  • 2/22/2022Luye Pharma and Biostar Agree to Co-market Anticancer Utidelone in Mai...
  • 2/22/2022Kexing Biopharm to Pair with AntiV BioPharma to Jointly Develop Small-...
  • 2/22/2022Stemirna gets ready for China's own mRNA Covid-19 vaccine as global mu...
  • 2/22/2022CDE Seeks Comments on Draft Chinese Translation and Implementation Sug...
  • 2/22/2022CDE Publicizes the Draft CDE Working Procedures for Accelerating Evalu...
  • 2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
  • 2/22/2022State Council Issues New Plan on Senior Population Development and Eld...
  • 2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...
  • 2/21/2022Is China's Healthcare Industry the Next Regulatory Flashpoint under Bi...
  • 2/21/2022Why Patient-Centric Innovation Holds the Key to Long-Term Business Suc...
  • 2/21/2022Inter-Provincial Pacts on Bulk-Buying Drugs Are on the Rise in China, ...
  • Page:163/789 Total number of articles:23668: [First][<<] [161] [162] [163] [164] [165] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group